Theralase Technologies Inc. (TLT) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.180x

Based on the latest financial reports, Theralase Technologies Inc. (TLT) has a cash flow conversion efficiency ratio of -0.180x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-1.23 Million ≈ $-889.90K USD) by net assets (CA$6.84 Million ≈ $4.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Theralase Technologies Inc. for the company's overall valuation and market capitalisation.

Theralase Technologies Inc. - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Theralase Technologies Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Theralase Technologies Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Theralase Technologies Inc. ranked by their cash flow conversion efficiency. Explore TLT cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Metagenomi, Inc. Common Stock
NASDAQ:MGX
-0.173x
Creas F&C Co.Ltd
KQ:110790
-0.010x
Visang Educati
KO:100220
-0.040x
Componenta Corp
HE:CTH1V
0.115x
Appasia Bhd
KLSE:0119
-0.022x
Highlight Communications AG
XETRA:HLG
-26.847x
Sinher Technology Inc
TW:4999
0.012x
Winner Group Enterprise Public Company Limited
BK:WINNER
-0.097x

Annual Cash Flow Conversion Efficiency for Theralase Technologies Inc. (2001–2025)

The table below shows the annual cash flow conversion efficiency of Theralase Technologies Inc. from 2001 to 2025. View Theralase Technologies Inc. stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$1.78 Million
≈ $1.29 Million
CA$-3.29 Million
≈ $-2.38 Million
-1.848x -14.88%
2024-12-31 CA$2.07 Million
≈ $1.50 Million
CA$-3.33 Million
≈ $-2.41 Million
-1.609x +24.73%
2023-12-31 CA$1.91 Million
≈ $1.38 Million
CA$-4.07 Million
≈ $-2.95 Million
-2.137x -28.78%
2022-12-31 CA$3.09 Million
≈ $2.24 Million
CA$-5.13 Million
≈ $-3.71 Million
-1.660x -108.79%
2021-12-31 CA$5.07 Million
≈ $3.67 Million
CA$-4.03 Million
≈ $-2.92 Million
-0.795x -63.83%
2020-12-31 CA$9.16 Million
≈ $6.63 Million
CA$-4.45 Million
≈ $-3.22 Million
-0.485x -2.38%
2019-12-31 CA$13.86 Million
≈ $10.02 Million
CA$-6.57 Million
≈ $-4.75 Million
-0.474x +61.07%
2018-12-31 CA$998.64K
≈ $722.40K
CA$-1.22 Million
≈ $-879.39K
-1.217x +41.54%
2017-12-31 CA$2.05 Million
≈ $1.48 Million
CA$-4.26 Million
≈ $-3.08 Million
-2.082x -142.84%
2016-12-31 CA$5.69 Million
≈ $4.12 Million
CA$-4.88 Million
≈ $-3.53 Million
-0.858x -7.39%
2015-12-31 CA$6.32 Million
≈ $4.57 Million
CA$-5.04 Million
≈ $-3.65 Million
-0.799x +27.19%
2014-12-31 CA$3.31 Million
≈ $2.39 Million
CA$-3.63 Million
≈ $-2.62 Million
-1.097x -111.05%
2013-12-31 CA$1.76 Million
≈ $1.28 Million
CA$-916.67K
≈ $-663.11K
-0.520x -105.54%
2012-12-31 CA$-64.73K
≈ $-46.82K
CA$-606.72K
≈ $-438.89K
9.373x +405.21%
2011-12-31 CA$455.16K
≈ $329.25K
CA$-1.40 Million
≈ $-1.01 Million
-3.071x -663.82%
2010-12-31 CA$2.53 Million
≈ $1.83 Million
CA$-1.02 Million
≈ $-735.94K
-0.402x -3323.44%
2009-12-31 CA$3.49 Million
≈ $2.52 Million
CA$-40.95K
≈ $-29.62K
-0.012x +92.02%
2008-12-31 CA$2.39 Million
≈ $1.73 Million
CA$-351.19K
≈ $-254.05K
-0.147x -41.17%
2007-12-31 CA$3.37 Million
≈ $2.44 Million
CA$-351.49K
≈ $-254.26K
-0.104x -1262.74%
2006-12-31 CA$3.37 Million
≈ $2.44 Million
CA$-25.78K
≈ $-18.65K
-0.008x -130.39%
2005-12-31 CA$3.39 Million
≈ $2.45 Million
CA$85.33K
≈ $61.73K
0.025x +130.40%
2004-12-31 CA$1.05 Million
≈ $762.12K
CA$-87.23K
≈ $-63.10K
-0.083x +82.82%
2003-12-31 CA$399.21K
≈ $288.78K
CA$-192.39K
≈ $-139.17K
-0.482x +13.24%
2002-12-31 CA$87.35K
≈ $63.19K
CA$-48.52K
≈ $-35.10K
-0.555x +7.87%
2001-12-31 CA$137.03K
≈ $99.13K
CA$-82.62K
≈ $-59.76K
-0.603x --

About Theralase Technologies Inc.

V:TLT Canada Medical Devices
Market Cap
$41.55 Million
CA$57.44 Million CAD
Market Cap Rank
#22684 Global
#818 in Canada
Share Price
CA$0.19
Change (1 day)
-2.63%
52-Week Range
CA$0.15 - CA$0.39
All Time High
CA$0.58
About

Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of energy activated small molecules and associated drug formulations in Canada, the United States, and internationally. The company operates in two segments, Drug Division and Device Division. It engages in the research and development of Rutherrin, an injectable form … Read more